Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Carey

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
MDM Policy & Practice|August 28, 2019
Factors Affecting Health Care Engagement of Patients With End-Stage Heart Failure: An Exploratory Survey StudyLisa Carey Lohmueller, Aakanksha Naik, Luke Breitfeller, et al.
The Journal of Allergy and Clinical Immunology|November 22, 2008
A desensitization protocol for the mAb cetuximabMaya R Jerath, Mildred Kwan, Mily Kannarkat, et al.
Breast Cancer Research and Treatment|June 15, 2011
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapseJ Chuck Harrell, Aleix Prat, Joel S Parker, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 18, 2019
A chemotherapy privileging process for advanced practice providers at an academic medical centerMichelle A Carrasquillo, Tyler A Vest, Jill S Bates, et al.
Tissue Engineering. Part A|July 21, 2015
Tissue-Specific Effects of Esophageal Extracellular MatrixTimothy J Keane, Aaron DeWard, Ricardo Londono, et al.
Breast Cancer Research and Treatment|September 27, 2014
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007Kathy D Miller, Sandra K Althouse, Lisle Nabell, et al.
Clinical Breast Cancer|December 15, 2010
Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancerKathy S Albain, Lisa Carey, William J Gradishar, et al.
Breast Cancer Research and Treatment|August 22, 2017
Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302)Judith O Hopkins, Jake Allred, Arti Hurria, et al.
Cancer Chemotherapy and Pharmacology|January 17, 2012
The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patientsChristine M Walko, Austin J Combest, Ivan Spasojevic, et al.
Journal of the National Cancer Institute|September 22, 2018
Endocrine Therapy Nonadherence and Discontinuation in Black and White WomenStephanie B Wheeler, Jennifer Spencer, Laura C Pinheiro, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
MDM Policy & Practice|August 28, 2019
Factors Affecting Health Care Engagement of Patients With End-Stage Heart Failure: An Exploratory Survey StudyLisa Carey Lohmueller, Aakanksha Naik, Luke Breitfeller, et al.
The Journal of Allergy and Clinical Immunology|November 22, 2008
A desensitization protocol for the mAb cetuximabMaya R Jerath, Mildred Kwan, Mily Kannarkat, et al.
Breast Cancer Research and Treatment|June 15, 2011
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapseJ Chuck Harrell, Aleix Prat, Joel S Parker, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 18, 2019
A chemotherapy privileging process for advanced practice providers at an academic medical centerMichelle A Carrasquillo, Tyler A Vest, Jill S Bates, et al.
Tissue Engineering. Part A|July 21, 2015
Tissue-Specific Effects of Esophageal Extracellular MatrixTimothy J Keane, Aaron DeWard, Ricardo Londono, et al.
Breast Cancer Research and Treatment|September 27, 2014
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007Kathy D Miller, Sandra K Althouse, Lisle Nabell, et al.
Clinical Breast Cancer|December 15, 2010
Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancerKathy S Albain, Lisa Carey, William J Gradishar, et al.
Breast Cancer Research and Treatment|August 22, 2017
Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302)Judith O Hopkins, Jake Allred, Arti Hurria, et al.
Cancer Chemotherapy and Pharmacology|January 17, 2012
The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patientsChristine M Walko, Austin J Combest, Ivan Spasojevic, et al.
Journal of the National Cancer Institute|September 22, 2018
Endocrine Therapy Nonadherence and Discontinuation in Black and White WomenStephanie B Wheeler, Jennifer Spencer, Laura C Pinheiro, et al.
Pageof 5